Basis: Current FMP quote-based enterprise value / matching reported total assets. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Assets ratio is 5.64x as of 2026-10-06T18:48:09.672Z.
Calculation as of: 2026-10-06T18:48:09.672Z.
Quote observation: 2026-10-06T18:44:56.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b7fd3b5d8e417d78924f6cd313032c2aac5600bd184120b35a4860f29c1b1599
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/ASSETS RATIO
5.64x
SECTOR MEDIAN · HEALTHCARE
1.58x
median of 781 covered companies
CURRENT VS SECTOR MEDIAN
+256.96%
vs the sector median at left
Tiziana Life Sciences Ltd
Market Cap
$68.40M
EV/Assets Ratio
5.64x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$68.60M
EV/Assets Ratio
N/A
TTM Avg
0.41x
3Y Avg
0.28x
5Y Avg
0.26x
Market Cap
$69.48M
EV/Assets Ratio
0.39x
TTM Avg
1.33x
3Y Avg
0.96x
5Y Avg
0.95x
Market Cap
$67.66M
EV/Assets Ratio
2.23x
TTM Avg
2.83x
3Y Avg
3.09x
5Y Avg
3.04x
Market Cap
$71.89M
EV/Assets Ratio
5.58x
TTM Avg
3.86x
3Y Avg
1.85x
5Y Avg
1.69x
Market Cap
$72.30M
EV/Assets Ratio
3.88x
TTM Avg
5.04x
3Y Avg
3.43x
5Y Avg
2.54x
| NAME | MARKET CAP | EV/ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tiziana Life Sciences Ltd (TLSA) | $68.40M | 5.64x | N/A | N/A | N/A |
| Fortress Biotech, Inc. (FBIO)vs › | $68.60M | N/A | 0.41x | 0.28x | 0.26x |
| Spero Therapeutics, Inc. (SPRO)vs › | $69.48M | 0.39x | 1.33x | 0.96x | 0.95x |
| Champions Oncology, Inc. (CSBR)vs › | $67.66M | 2.23x | 2.83x | 3.09x | 3.04x |
| Cingulate Inc. (CING)vs › | $67.02M | 1.36x | 1.40x | 4.90x | 17.42x |
| iBio, Inc. (IBIO)vs › | $66.56M | 0.12x | 1.64x | 0.92x | 0.73x |
| XBiotech Inc. (XBIT)vs › | $66.16M | N/A | 0.17x | 0.16x | 1.19x |
| MindWalk Holdings Corp. (HYFT)vs › | $71.89M | 5.58x | 3.86x | 1.85x | 1.69x |
| Gain Therapeutics, Inc. (GANX)vs › | $72.30M | 3.88x | 5.04x | 3.43x | 2.54x |
| Verrica Pharmaceuticals Inc. (VRCA)vs › | $72.16M | 1.74x | 2.00x | 2.23x | 2.52x |
EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
